The ABPI welcomes Jeremy Hunt’s announcement today of a ‘Sunshine Rule’, designed to improve transparency between healthcare professionals and industry as a positive addition to the existing industry-led drive for disclosure and transparency around industry relationships with healthcare professionals (HCPs).Read more
In the UK, we have an enviable track record for leadership in experimental medicine (the investigation of disease processes and responses to developmental medicines in humans). However, while the UK has strengths, there are also challenges, and we know that more can be done to improve leadership in this area. Read more
The ABPI and DH have agreed to amend the 2014 Pharmaceutical Price Regulation Scheme (PPRS) to clarify the way in which spending under the Cancer Drugs Fund is treated by the Scheme.Read more
I began today by reading an excellent article, a summary of all of the reasons why conducting research and delivering a meaningful result that advances science is not a straightforward or easy process, and why science only really advances when there are enough trained eyeballs staring at a problem to challenge and self-correct. Read more
Our website is not compatible with Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version or use another browser.